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Patrick A. Lewis1,2 and Claudia Manzoni1,2*
Abstract
Background: Genome wide association studies (GWAS) have helped identify large numbers of genetic loci that
significantly associate with increased risk of developing diseases. However, translating genetic knowledge into
understanding of the molecular mechanisms underpinning disease (i.e. disease-specific impacted biological
processes) has to date proved to be a major challenge. This is primarily due to difficulties in confidently defining
candidate genes at GWAS-risk loci. The goal of this study was to better characterize candidate genes within GWAS
loci using a protein interactome based approach and with Parkinson’s disease (PD) data as a test case.
Results: We applied a recently developed Weighted Protein-Protein Interaction Network Analysis (WPPINA) pipeline
as a means to define impacted biological processes, risk pathways and therein key functional players. We used
previously established Mendelian forms of PD to identify seed proteins, and to construct a protein network for
genetic Parkinson’s and carried out functional enrichment analyses. We isolated PD-specific processes indicating
‘mitochondria stressors mediated cell death’, ‘immune response and signaling’, and ‘waste disposal’ mediated
through ‘autophagy’. Merging the resulting protein network with data from Parkinson’s GWAS we confirmed
10 candidate genes previously selected by pure proximity and were able to nominate 17 novel candidate genes
for sporadic PD.
Conclusions: With this study, we were able to better characterize the underlying genetic and functional
architecture of idiopathic PD, thus validating WPPINA as a robust pipeline for the in silico genetic and functional
dissection of complex disorders.
Keywords: Bioinformatics, Networks, Functional genomics, Protein-protein interactions, Pathways,
Neurodegeneration, Parkinson’s disease, GWAS
Background
In the past decade, high throughput technologies, such
as DNA microarray, exome and genome sequencing,
have provided investigators with an extensive catalogue
of genes and genetic variations associated with complex
disorders [1].
Parkinson’s disease (PD) is a complex neurodegenerative
condition; to date, familial PD is linked to 14 Mendelian
genes (Table 1) [2], accounting for 1–5% of all cases [3],
whilst for idiopathic PD (> 90% of all cases) multiple
genome-wide association studies (GWAS) have identified
over 30 risk loci throughout the human genome [4].
Importantly, a number of the most significant single
nucleotide polymorphisms (SNPs) identified by the PD
GWA studies map either directly or in close proximity to
previously identified Mendelian genes (e.g. LRRK2, SNCA
and GBA) indicating that such genes likely contribute to
disease over a continuum of strong (Mendelian forms)
and small to moderate (GWAS hits) effect size [5]. Yet,
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for the majority of the PD genome wide risk loci (and
generally in GWAS), there is currently no consensus on
how to select candidate genes in association with the most
significant risk SNP(s) [6].
Interpreting GWAS results is a challenging task [6, 7]
as not only is it difficult to confidently define the au-
thentic associated marker (the top identified SNP might
be in linkage disequilibrium [LD] with the real
associated SNP), but also it is now recognized that the
practice of choosing candidate genes by proximity to a
strongly associated SNP is unlikely accurate [8–10].
Furthermore, there are significant challenges in then
characterising functional/biological effects to the top
SNPs. This clearly indicates that making the step from
genomic insight(s) to functional translation is currently
arduous due to the limited success in progressing from
genomic loci to candidate genes, coupled with the preva-
lent functional practice of studying one gene at a time.
In this study, we applied a systematic computational ap-
proach to investigate the interactome of the PD-Mendelian
genes through weighted protein-protein interaction
network analysis (WPPINA) [11] as a means to define
PD-specific impacted pathways and stratify candidate
genes within PD-GWAS loci. Specifically, we selected
proteins encoded by PD-Mendelian genes as seeds, and
harvested data of wet-lab proven protein-protein inter-
actors (PPI) to build the PD-interactome for which we
then performed functional annotation analysis to high-
light impacted biological processes and to list all the
proteins contributing to these systems. Finally, we
mapped the genes encoding all such proteins to the loci
highlighted in the PD meta-analysis [4] to assist identi-
fication of candidate genes driving risk in sporadic PD
on the basis of available functional knowledge.
Using PD as a case study, we demonstrate that WPPINA,
in combination with genomic approaches, is a powerful
and adaptable tool to assess and prioritize candidate genes
within risk-loci of complex disorders.
Results
Design
We sought to consider the interactomes associated with
the parkinsonian syndromes, which manifest in classical
PD - the focus of the current study – and a subset of cases
diagnosed with frontotemporal dementia (FTD) with
parkinsonism and in a group of conditions classified under
the umbrella term ‘parkinsonian spectrum’ (PS, see also
Additional files 1 and 2: Table S1). We used all known
Mendelian genes associated with these conditions as seeds
(Table 1) to build syndrome-specific networks to: i) high-
light syndrome-specific impacted biological processes and
relevant nodes therein, and; ii) aid prioritization of candi-
date genes within the PD-GWAS loci. In this fashion, we
were able to test for specificity of our method prior to car-
rying forward the PD-GWAS candidate genes prioritization
on the basis of the PD-specific impacted biological pro-
cesses and the key proteins therein.
Table 1 List of seeds
PD Parkinson’s Disease, FTD frontotemporal dementia, PS
parkinsonian syndromes
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Network construction and topological analysis
For each Mendelian gene used as a seed the WPPINA
builds a protein network composed of the seeds, their
direct interactors (first layer nodes) and the direct inter-
actors of each first layer node (second layer nodes).
The 3 individual first-layer-networks (PD, FTD and
PS) are shown in Fig. 1a-c. The combination of the 3
networks generated a nearly completely connected
first-layer-network (Fig. 1d). Due to the seed centric ap-
proach used to construct the network, the first layer of
a network is partially dependent upon hypothesis
driven experiments. Moreover, the interactomes are
subject to ascertainment bias resulting in interactomes
of different sizes [12]. The ascertainment bias is an
intrinsic property of the PPI networks, yet the seed cen-
trality bias can be diluted by scaling up the network to
the second layer, therefore including nodes that were
not necessarily studied as direct interactor(s) of the
seeds under investigation [11].
The construction of the second layer resulted in a
comprehensive network made of 5414 nodes and 18,492
undirected edges (Fig. 1e); the seed-centrality issue was
diluted as confirmed by an increase in average number
of neighbors and connection density, and by a decrease
of the average shortest path (Additional file 3). The ana-
lysis of the first + second layer networks led to the iden-
tification of inter-interactome hubs (IIHs) that are nodes
with a degree of interactome connection (IDC) ≥ 0.6
(Additional file 4). These nodes represent the shortest
path to connect more than 60% of the seed genes,
therefore (based on the network parsimony hypothesis
[13]) it is reasonable to expect these to reside in disease
relevant pathways, congruent with the majority of the
seeds, and therefore at the core of the syndrome-specific
network.
Network functional analysis
We first analyzed the entire network (input of 5414
nodes) for enrichment of Gene Ontology (GO) bio-
logical processes (BPs) terms (Additional file 5); we
then applied the same procedure to the IIHs for PD,
FTD and PS separately (Additional files 6, 7 and 8) [12]
highlighting a subset of semantic classes indicative of
syndrome-specific biological processes (Additional file
9).
Although ‘RNA metabolism’, ‘organelles’, ‘adhesion’,
‘cytoskeleton’ and ‘chromatin’ are general terms, a number
of functional blocks clearly supported syndrome-specific
processes (Fig. 2 and Additional file 10) cell cycle and
DNA metabolism (semantic classes: ‘cell cycle check-
points’, ‘DNA damage check point’ and ‘repair’) were spe-
cific to FTD/PS. Cell death pointed to ‘intrinsic apoptosis‘
for both FTD/PD indicating ‘DNA damage response’ as
specific to FTD, and ‘mitochondria stressors’ as specific to
PD/PS. Stress indicated ‘oxidative stress’ as a common se-
mantic class across all syndromes: ‘ER stress’ was shared
across FTD and PD – complexes that activate ‘DNA
damage response’ were however (again) unique for FTD –
whilst ‘cell death via mitochondria’ was unique for PD.
These very links were further supported by localization
Fig. 1 First layer protein networks. a. FTD (blue nodes, 272 nodes and 304 edges); b. PS (orange nodes, 140 nodes and 133 edges); c. PD (red
nodes, 286 nodes and 332 edges); d. Combination of a-b-c into a single network: the grey nodes represent proteins that are shared between
a-b, a-c, b-c or a-b-c. Networks are reported as organic layout to highlight clustering properties. e. Seeds + first and second layer interactors
combined in the final network, purple = seeds; green = IIHs
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that pointed at the ‘nucleus’ for FTD/PS and the ‘mito-
chondria’ for PS/PD. Development suggested ‘cell growth’
for FTD and ‘neuronal/axonal development’ for PS, this
being in line with semantic classes indicating ‘growth fac-
tors’ within signaling, that were specific for FTD and PS.
Conversely, the indication of ‘cytokines’, ‘immune recep-
tors’, ‘innate immune system’ as specific to PS and PD in
the immune system functional block was supported by a
plethora of immune signaling semantic classes in the
signaling functional block for PS/PD (Additional file 10).
Finally, waste disposal was enriched in all 3 conditions;
however, FTD was specifically characterized by semantic
classes such as the ‘ubiquitin proteasome system’ and the
‘unfolded protein response’, whilst PD by ‘autophagy’.
Functional annotation analysis performed through Pan-
ther replicated 95.5% of the g:Profiler findings (Additional
file 11).
PD-GWAS candidate genes prioritization
We selected the functional blocks defined by PD-specific
IIHs (Additional file 12), as they indicate conserved func-
tions across all the Mendelian forms of PD, and extracted
the list of proteins contributing to them in the complete
PD-specific network (Additional file 13). We then used
the significant PD-SNPs (n = 32) from the GWAS to de-
fine cis-haplotypes (Additional file 14) and map ORFs
therein. Finally, we compared the ORFs with the proteins
contributing to the enrichment of the PD-specific func-
tional blocks: 19 genes were in cis-haplotypes defined
by LD r2 ≥ 0.8, 2 genes in LD r2 ≥ 0.7, 2 genes in LD
r2 ≥ 0.6, and 4 genes in LD r2 ≥ 0.5 with the top SNP
of a risk locus, respectively, leading to the
prioritization of a total of 27 candidate genes within
the 32 PD-loci (Fig. 3).
Ten/27 candidate genes (5 of which are also Mendelian)
– GBA, SYT11, SNCA, RAB7L1(RAB29), INPP5F, DLG2,
LRRK2, GCH1, MAPT, and RAI1 – previously selected by
proximity were confirmed by our functional approach.
The remaining 17/27 candidate genes – ZBTB7B, MUC1,
CLK2, DAP3, SCAMP3, ADAM15, RUSC1, SHC1, ARH-
GEF2, KAT8, STX4, IGF2BP3, PPM1L, DCUN1D1, NSF,
BAG3 and TOM1L2 – are to be regarded as novel PD
candidate genes. Cell type specific expression for each pri-
oritized candidate gene was calculated from the dataset
generated by Zhang et al. [14] showing that neurons and
mature astrocytes almost equally share expression of the
prioritized candidate genes (Additional files 15 and 16).
To validate this analysis, we ran 100,000 random simu-
lations. The p-values associated with the experimental
analysis in comparison with the random distribution
showed strong statistical significance (Additional file 17,
p = 0.004 for LD r2 ≥ 0.5 and p = 0.005 for LD r2 ≥ 0.8).
Analytic p-values values generated using the hypergeo-
metric distribution also led to statistically significant re-
sults (p = 0.009 for LD r2 ≥ 0.5 and p = 0.012 for LD r2 ≥
0.8). We undertook an additional validation step by
assessing the total number of annotations reported in GO
for each ORF within the analyzed haplotypes to verify
Fig. 2 Most impacted biological processes. Three major impacted functional blocks – ‘cell cycle & cell death’, ‘signalling’ and ‘waste disposal’ –
differently segregated across the different syndromes (PD: red, FTD: blue and PS: orange)
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potential annotation bias possibly impacting the specificity
of the GWAS loci prioritization. As shown in Additional
file 18, the number of annotations per genes in GO does
not affect prioritization specificity.
Discussion
Familial and sporadic PD cases associate with highly/
moderately penetrant variants in a number of Mendelian
genes and multiple risk loci with small to moderate ef-
fect size, respectively. Despite an abundance of genetic
data, translating PD genetics into understanding of the
functional and molecular mechanisms underlying PD
pathogenesis is a challenging task. For Mendelian genes,
this is partially due to differences in the pace of genetic
data generation (fast) versus functional and molecular
assessments (slow) that still evaluate one gene at a time.
For sporadic cases, their association with multiple risk
markers (that indicate loci rather than genes) results in
additional theoretical and practical issues affecting the
design of functional experiments.
A number of methods to prioritize genes within
GWAS loci have recently emerged: burden scoring at
gene or pathway level [15, 16], GWAS data integration
with cis-eQTL signals or epigenetic markers [17–20],
and PPIs-based methods [9, 21]. However, while these
hold much promise, none has yet solved the issue of
confidently prioritizing genes within GWAS loci and it
is still the case that in published GWAS nominated
genes are assigned to the top SNPs predominantly by
proximity, an approach that not only is arbitrary but also
inaccurate and ineffective to gather insight on molecular
mechanisms impacted in disease pathogenesis [8].
Therefore, there is an urgent requirement for additional
pipelines to further and better characterize GWAS loci
as well as the impacted biological processes, risk path-
ways and therein key functional players for potential fu-
ture targeting is real [1, 22].
In this view, our recently developed pipeline, WPPINA
[11], is complementary to existing models given that it
builds protein networks as a direct function of the disease
under investigation (i.e. on the basis of their Mendelian
genetics). By applying this pipeline to PD, FTD and PS we
were able to highlight syndrome-specific PPI networks,
impacted biological processes and associated functional
players at the core of each disease (Fig. 2). We found that
specific processes were differentially relevant across the 3
syndromes: ‘immune response’, particularly ‘signaling in
immune response’, was relevant for PD and PS, ‘DNA
Fig. 3 PD-GWAS gene prioritization. Significant SNPs from PD-GWAS and ORFs in LD (from r2 > 0.5 to r2 > 0.8) are shown. Part A contains
significant SNPs as per joint analysis; part B contains significant SNPs as per discovery phase. The candidate genes based on proximity are
summarized in the column with light yellow background. Newly proposed candidate genes identified on the basis of our analysis of the
functionally relevant proteins in the PPI network are summarized in the column with light blue background. Here genes in black font confirm
previous assignments by proximity, whilst genes in red font are the novel candidate genes for sporadic PD
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damage response’ was relevant for FTD only, and ‘waste
disposal’ was differentially relevant for PD (i.e. ‘autophagy’)
and FTD (i.e. ‘unfolded protein response’ and ‘ubiquitin
proteasome system’). Particularly, we isolated ‘mitochon-
dria stressors’ and ‘mitochondria mediated cell death’, ‘im-
mune response and signaling’ (i.e. ‘immune system
receptors’ and ‘cytokine signaling’), and ‘waste disposal’
mediated through ‘autophagy’ as PD-specific processes.
After verifying the suitability of our approach in
highlighting syndrome-specific impacted biological pro-
cesses, we then focused on the PD-interactome to
prioritize candidate genes within PD-GWAS loci (Fig. 3)
[4] on the basis of functional relevance rather than prox-
imity. We used the totality of the proteins indicated by
the PD-specific processes and mapped them onto the
PD-GWAS loci, confirming 10 candidate genes (previ-
ously nominated by proximity) and identifying 17 novel
candidate genes (Fig. 3 and Additional file 15) for spor-
adic PD. Of note, for some of the loci we identified more
than one candidate gene. This could be due to a number
of reasons: i) the top SNP at the risk locus may mask a
lower (but still biologically significant) signal of a sec-
ond, independent SNP [23], and/or; ii) the same SNP(s)
might influence more than one ORF [24] as, for ex-
ample, in the case of rs34311866 for which classical
wet-lab approaches prioritized different genes (i.e. GAK
and TMEM175) [25, 26]. It is also noteworthy that we
were not able to assign a gene to every locus. This might
reflect that: i) the PPI network is incomplete (i.e. partly
because not all experimental data has been captured by
manual curation, and partly because the network can
only be as complete as the experiments that have been
performed and published), and/or; ii) we may have low-
ered the number of potentially positive nodes by using a
stringent filtering to only retain robustly validated inter-
actors in the network. Finally, the risk loci may target
functional elements that reside in -trans rather than in
-cis (e.g. distal enhancers or silencers) or non-coding
RNAs, rather than protein coding genes [6].
Conclusions
Through this in silico study of a multifactorial, complex
neurodegenerative disorder, we show that our pipeline can
be applied to: i) define disease-specific biological processes
on the basis of known Mendelian genes, and; ii) provide a
list of proteins involved in disease-specific processes that
can be used to prioritize candidate genes in GWAS loci.
This pipeline aids in expanding on the genetic and func-
tional architecture underlying idiopathic forms of disease.
In doing so, it provides the basis for further genetic (e.g.
such list of proteins/genes might be screened for rare
variants within whole exome sequencing data sets) and
hypothesis-driven functional studies to validate-risk
pathways as well as identify targets for the development of
therapies in the future.
Methods
Methods are described in detail in the Additional file 1.
Construction of the PPI network
PPIs of Mendelian-PD gene products were downloaded
for each seed protein as MITAB 2.5 files (January-2016)
from the IntAct [27], BioGRID [28], InnateDB, InnateD-
B-all, InnateDB-IMEx [29] and MINT [30] databases by
means of the PSICQUIC platform (http://www.ebi.ac.uk/
Tools/webservices/psicquic/view/main.xhtml) developed
by the IMEx consortium [31]. All PPIs underwent quality
control (QC) and filtering. Only human interaction and
experimentally proven physical interaction were retained
(predicted interactions and expanded complexes were re-
moved). The interactions were then scored and thre-
sholded taking into consideration the number of
different publications and methods reporting the inter-
action (see [11] and Additional file 1 for details).
Polyubiquitin-C, B and D (UBC, UBB and UBD) were
excluded from the network as they may indicate unspecific
binding of ubiquitin to proteins tagged for degradation.
Topological analysis
The inter-interactome degree (IID) for each single node
was calculated based on the number of different interac-
tomes that node belonged to. The interactome connec-
tion degree (ICD) of a node equates to the IID divided
by the total number of seeds in the network and ranges
between 1 (nodes able to bridge all the interactomes in
the network) and 1/number of seeds (nodes unable to
bridge any interactomes in the network). Nodes with
IDC ≥ 0.6 are inter-interactomes hubs (IIHs).
Functional enrichment analysis and replication
We performed Gene Ontology (GO) [32] terms enrich-
ment analyses in g:Profiler (g:GOSt, http://biit.cs.ut.ee/
gprofiler/) [33] (October–November 2016) and repli-
cated in PANTHER (June 2017). Enriched GO-BP terms
were grouped into custom-made ‘semantic classes’; simi-
lar semantic classes were grouped into hierarchical
groups called ‘functional blocks’ (Additional file 1).
Gene prioritization – GWAS
We used thirty-two relevant SNPs as per the PD
meta-analysis (form discovery phase and/or joint analysis)
[4]. The genes mapping to the GWAS-loci (SNPSNAP,
reference EU 1000G; locus definition by linkage disequi-
librium (LD) r2 > 0.5) were matched with those encoding
proteins contributing to the PD-specific risk-processes
highlighted by WPPINA to aid prioritization of genes
within the PD-GWAS loci. Results were statistically
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validated by generating 100,000 random gene-sets of sizes
similar to the lists of open reading frames (ORFs) in LD
with the PD-GWAS SNPs. P-values were calculated con-
sidering the total number of random matches falling
above the actual number of experimental matches divided
by the total number of trials. Analytic p-values were also
calculated by using the hypergeometric distribution. An
additional assessment was performed by evaluating the
number of annotations for each gene reported in GO (GO
annotation service http://amigo.geneontology.org/grebe)
to verify whether differences in the annotation sizes might
have influenced and driven gene prioritization.
Cell type expression
We evaluated cell specific expression profile for genes
prioritized in each PD locus. The individual expression
FPKM data were downloaded for human temporal lobe
cortex mature astrocytes, neurons, microglia, oligoden-
drocytes and endothelial cells from Additional file 1 of
Zhang et al. [14].
Software
Data was handled, filtered and scored through in-house
R scripts (https://www.r-project.org/) as described before
[11]. The final network was visualized through the freely
available Cytoscape 2.8.2 software and analyzed through
the network analysis plug-in [34].
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FTD, orange for PS and red for PD. (JPG 790 kb)
Additional file 10: Functional blocks supporting syndrome-specific co-
herent patterns for PD, FTD and PS. Each semantic class is represented at
the bottom of the x axis. Each functional block is found
at the top of the x axis. The contribution of each syndrome to each
semantic class is defined by colour-coded dots representing single GO
terms within each semantic class (PD: red dots, FTD blue dots and PS:
orange dots). The pie charts represent the relative distribution of different
semantic classes per functional block for either syndrome. (JPG 228 kb)
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(XLSX 117 kb)
Additional file 12: List of GO BPs extracted from the g:Profiler
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Additional file 15: PD-GWAS gene prioritization. Significant SNPs from
PD-GWAS and the number of ORFs in LD (from r2 > 0.5 to r2 > 0.8) are
shown. Part A contains significant SNPs as per joint analysis, part B con-
tains significant SNPs as per discovery phase. The candidate genes based
on proximity are summarized as suggested in the original GWAS. Newly
proposed candidate genes within each are identified on the basis of our
analysis of the functionally relevant proteins in the PPI network. Genes
previously selected by proximity and now also confirmed by functional
analysis of the PD-network are in bold font. The top pie chart represents
the distribution of proteins across the different relevant processes. In the
final column the cell type with major expression (> 5% of average expres-
sion) is reported as calculated from the dataset generated by Zhang et al.
[13] (A = mature astrocytes, N = neurons, M =microglia, O = oligodendro-
cytes and, E = endothelial cells). The bottom pie chart represents the dis-
tribution of proteins based on cell type expression in human temporal
lobe cortex. (JPG 349 kb)
Additional file 16: Functions of newly prioritized candidate genes.
(XLSX 15 kb)
Additional file 17: .GO Annotation Frequency. Proteins whose ORF is in
the LD blocks around the prioritized SNPs in the PD-GWAS have been
evaluate in terms of numbers of GO annotations present in GO for that
specific ORF. In red are reported the proteins that correspond to genes
that we prioritized with our analysis. In grey, all the other genes are re-
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